Allergan's anti-PTAB patent deal with the Mohawks looks to be a potential US game-changer
Register to access two of our subscriber only articles per month.
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
Author | Editor-in-chief
@IAM_Alerts Data monetisation drives Sanofi’s $180 million investment in AI biotech Owkin. The deal is one of several recent de… https://t.co/cJ4ktA8jRd Read more
@IAM_Alerts Congratulations to the @EPOorg, voted top for patent quality once more by IAM readers https://t.co/TEI7qrf2wB https://t.co/KBORVduTDD Read more
@IAM_Alerts This week’s Sunday Supplement is now out, including: IBM IP chief talks strategy; Ericsson’s Vonage patent haul; Ho… https://t.co/S81XUI5Xlg Read more
@IAM_Alerts RT @TwittenByStorm: @IAM_Alerts Okay, I’ll bite.
Sometimes events come along that are bigger than IP, and we must defer to the non-IP peop… Read more